Table 3.
Multimodal imaging findings of patients according to each group
| Parameters | Myopic CSC (N = 8) |
Myopic PNV (N = 7) |
|---|---|---|
| Funduscopy | ||
| Tessellated fundus | 0/8 | 1/7 (14.3%) |
| Diffuse atrophy | 6/8 (75%) | 6/7 (85.7%) |
| Patchy atrophy | 2/8 (25%) | 0/7 |
| Macular atrophy | 0/8 | 0/7 |
| Staphyloma | 2/8 (25%) | 2/7 (28.6%) |
| OCT | ||
| Pachyvessel beneath SRF | 8/8 (100%) | 7/7 (100%) |
| DSM | 4/8 (50%) | 2/7 (28.6%) |
| DLS | 0/8 | 5/7 (71.4%) |
| IRC | 0/8 | 2/7 (28.6%) |
| Subretinal HF | 6/8 (75%) | 4/7 (57.1%) |
| FA | ||
| Leakage in early phase | 0/8 | 1/7 (14.3%) |
| Stippled or diffuse leakage in late phase | 0/8 | 6/7 (85.7%) |
| ICGA | ||
| Choriodal vascular hyperpermeability | 8/8 (100%) | 5/6 (83.3%) |
| Punctate hyperfluorescent spot | 5/8 (62.5%) | 5/6 (83.3%) |
| OCTA | ||
| Positive vascular density in outer retinal slab | 0/6 | 5/5 (100%) |
OCT Optical coherence tomography, OCTA Optical coherence tomography angiography, FA Fluorescence angiography, ICGA Indocyanine green angiography, SRF Subretinal fluid, DSM Dome-shaped macula, DLS Double layer sign, IRC Intraretinal cyst, HF hyper-reflective foci, CSC Central serous chorioretinopathy, PNV, Pachychoroid neovascularization